News-Papers
Testimonial
Video Gallery
Search
Follow us...
Latest
- Melatonin prevents inflammation and oxidative stress caused by abdominopelvic and total body irradiation of rat small intestine
- Effects of melatonin and vitamin E on oxidative-antioxidative status in rats exposed to irradiation
- Modulation of apoptosis by melatonin for improving cancer treatment efficiency: An updated review
- Evaluation of the radioprotective effects of melatonin against ionizing radiation-induced muscle tissue injury
- XFEL structures of the human MT2 melatonin receptor reveal the basis of subtype selectivity
- Structural basis of ligand recognition at the human MT1 melatonin receptor
- Concomitant Expression of Prolactin Receptor and TGFβ Receptors in Breast Cancer: Association with Less Aggressive Phenotype and Favorable Patient Outcome
- An in vivo half-life extended prolactin receptor antagonist can prevent STAT5 phosphorylation
- Melatonin is an appropriate candidate for breast cancer treatment: Based on known molecular mechanisms
- COX-2 mediates tumor-stromal prolactin signaling to initiate tumorigenesis
- A Prospective Study of Serum Vitamin E and 28-Year Risk of Lung Cancer
- Differential MicroRNA Expression of miR-21 and miR-155 within Oral Cancer Extracellular Vesicles in Response to Melatonin
- Association between nighttime-daytime sleep patterns and chronic diseases in Chinese elderly population: a community-based cross-sectional study
- Protein and energy metabolism with biosynthetic human growth hormone after gastrointestinal surgery
- Pit-1 is expressed in normal and tumorous human breast and regulates GH secretion and cell proliferation
- Autocrine stimulation of human mammary carcinoma cell proliferation by human growth hormone
- The oncogenic potential of growth hormone
- Absence of serum growth hormone binding protein in patients with growth hormone receptor deficiency (Laron dwarfism)
Most Read
- All-trans-retinoic acid and cancer
- The Di Bella Method (DBM)
- Biography
- About melatonin - 1996
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Bibliography
- Somatostatin in oncology, the overlooked evidences
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Vademecum
- Frequently Asked Questions
- How effective is chemo therapy?
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Complete objective response to biological therapy of plurifocal breast carcinoma
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- Malignant pleural mesothelioma, stage T3-T4 - Consideration of a case study
- Novel synergistic mechanism for sst2 somatostatin and TNFalpha receptors to induce apoptosis: crosstalk between NF-kappaB and JNK pathways